Zobrazeno 1 - 10
of 95
pro vyhledávání: '"M V, Zavyalova"'
Autor:
V. M. Perelmuter, E. S. Grigoryeva, O. E. Savelieva, V. V. Alifanov, E. S. Andruhova, M. V. Zavyalova, O. D. Bragina, E. Yu. Garbukov, M. E. Menyailo, A. A. Khozyainova, E. V. Denisov, N. V. Cherdyntseva, L. A. Tashireva
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Following the discovery of circulating tumor cells (CTCs) in the peripheral blood of cancer patients, CTCs were initially postulated to hold promise as a valuable prognostic tool through liquid biopsy. However, a decade and a half of accumul
Externí odkaz:
https://doaj.org/article/962192a563d74d2db34135b7524661bd
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 1, Pp 74-81 (2023)
Background. Lymph node metastasis in breast cancer is not only a variant of cancer progression, but is also associated with the development of hematogenous metastases. The LIMCH1 protein is involved in the mesenchymal type of migration due to the act
Externí odkaz:
https://doaj.org/article/fc2b09f74a93448eac5f13a04caafdb6
Autor:
E. S. Grigoryeva, L. A.Tashireva, V. V. Alifanov, O. E. Savelieva, S. V. Vtorushin, M. V. Zavyalova, O. D. Bragina, E. Y. Garbukov, N. V. Cherdyntseva, E. L. Choinzonov, V. M. Perelmuter
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Molecular subtype of breast cancer has a great clinical significance and used as one of the major criteria for therapeutic strategy. Recently, for anticancer therapy, the trend for oncologists is the predominant determination of biomarkers i
Externí odkaz:
https://doaj.org/article/2abc9387ea4d4452b6031f686ca6e62a
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 5, Pp 59-68 (2022)
Breast cancer is the most common cancer and the leading cause of cancer death in woman of childbearing age. Tumor progression depends on the character of stromal-parenchymal interactions. Tumor microenvironment exerts a key influence on tumor progres
Externí odkaz:
https://doaj.org/article/8338638d53744590af4f45165147fdc2
Autor:
M. V. Zavyalova, D. M. Loos, D. S. Pismenny, A. A. Durova, E. S. Andryukhova, E. O. Rodionov, S. V. Miller, S. A. Tuzikov, O. V. Pankova, L. A. Tashireva, S. V. Vtorushin, V. M. Perelmuter
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 5, Pp 69-81 (2022)
The aim of the study: to examine the relationship between the morphological diversity of non-small cell lung cancer and the frequency of lymph node metastasis in groups of patients with different epithelial conditions in the bronchi adjacent to the t
Externí odkaz:
https://doaj.org/article/ba516f1d1385401a8d8b0b48f2eec6a4
Autor:
V. M. Perelmuter, E. S. Grigorieva, M. V. Zavyalova, L. A. Tashireva, V. V. Alifanov, O. E. Saveleva, S. V. Vtorushin, E. L. Choynzonov, N. V. Cherdyntsevа
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 4 (2022)
Introduction. Ability of circulating tumor cells (CTC) initiate metastases in distant sites is associated primarily with their resistance to apoptosis which allows them to retain viability in the blood. Knowledge of phenotypical signs associated with
Externí odkaz:
https://doaj.org/article/e528649f1cf3493eb8d18b97772c0069
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 4, Pp 30-37 (2021)
Background. The identification of predictive molecular markers of luminal breast cancer will help to assess the risk of developing distant metastases and determine a personalized approach to predicting the outcome of the disease during hormone therap
Externí odkaz:
https://doaj.org/article/03c17bacfbd444c29f245f45283192d2
Autor:
D. S. Pismenny, O. E. Savelieva, M. V. Zavyalova, E. O. Rodionov, L. A. Tashireva, S. A. Tuzikov, O. V. Pankova, V. M. Perelmuter
Publikováno v:
Сибирский онкологический журнал, Vol 19, Iss 3, Pp 54-63 (2020)
Introduction. The development of inflammation is characterized by changes in blood hematology parameters and indices. Various inflammatory parameters are used to assess the inflammatory status (IS) during cancer treatment. Recent studies have reveale
Externí odkaz:
https://doaj.org/article/7268bbf69c584d3e8327b45dfb9bf9bc
Publikováno v:
Сибирский онкологический журнал, Vol 19, Iss 3, Pp 146-155 (2020)
Purpose of the study: to review available data on the role and significance of GATA3, FOXA1 and ELF5 transcription factors in the pathogenesis, progression and therapy resistance of breast cancer.Material and Methods. The Medline and PubMed databases
Externí odkaz:
https://doaj.org/article/fd1eaa3fe18547dba56c3c42635a6b2e
Autor:
N. N. Babyshkina, T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, N. V. Cherdyntseva
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 1, Pp 13-20 (2020)
Background. Identification of predictive molecular markers of triple-negative breast cancer (TNBC) will enable the evaluation of the efficacy of neoadjuvant chemotherapy (NACT) and define optimum approaches for the prognosis of the disease course in
Externí odkaz:
https://doaj.org/article/13d96cc9b8db415297b267f633b4c6e7